Evaluating the Content Validity, Clarity, and Relevance of Two Patient-Reported Outcomes for Use With Adults With EGFR-Mutated NSCLC

Evaluating the Content Validity, Clarity, and Relevance of Two Patient-Reported Outcomes for Use With Adults With EGFR-Mutated NSCLC

Introduction: NSCLCs account for most lung cancers; approximately 30% involve a mutation in the EGFR gene. This study sought to identify one or more patient-reported outcome (PRO) measures relevant for use in clinical trials to assess symptoms and health-related quality of life in this population. M...

Full description

Bibliographic Details
Main Authors: Marcia K. Horn, JD, Kevin Liu, PharmD, Susan D. Mathias, MPH, Hilary H. Colwell, MPH, Tracy Li, PhD, Parthiv Mahadevia, MD, Renee F. Pierson, MBA
Format: Article
Language:English
Published: Elsevier 2021-08-01
Series:JTO Clinical and Research Reports
Subjects:
Non-small cell lung cancer
Patient-reported outcomes
Exon 20 insertion mutation
Epidermal growth factor receptor
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364321000576

Internet

http://www.sciencedirect.com/science/article/pii/S2666364321000576

Similar Items